Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.
Ura T, Hironaka S, Tsubosa Y, Mizusawa J, Kato K, Tsushima T, Fushiki K, Chin K, Tomori A, Okuno T, Matsushita H, Kojima T, Doki Y, Kusaba H, Fujitani K, Seki S, Kitagawa Y. Ura T, et al. Among authors: tsushima t. Esophagus. 2023 Apr;20(2):272-280. doi: 10.1007/s10388-022-00968-9. Epub 2022 Nov 22. Esophagus. 2023. PMID: 36427158 Clinical Trial.
Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.
Sakamoto T, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Machida N, Todaka A, Tomita H, Tsushima T, Taniguchi H, Hamauchi S. Sakamoto T, et al. Among authors: tsushima t. Int J Clin Oncol. 2010 Jun;15(3):287-93. doi: 10.1007/s10147-010-0054-9. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217447
Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.
Taniguchi H, Yamazaki K, Boku N, Funakoshi T, Hamauchi S, Tsushima T, Todaka A, Sakamoto T, Tomita H, Machida N, Taku K, Fukutomi A, Onozawa Y, Tsubosa Y, Sato H, Nishimura T, Yasui H. Taniguchi H, et al. Among authors: tsushima t. Int J Clin Oncol. 2011 Aug;16(4):359-65. doi: 10.1007/s10147-011-0192-8. Epub 2011 Feb 24. Int J Clin Oncol. 2011. PMID: 21347631
Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
Hironaka S, Tsubosa Y, Mizusawa J, Kii T, Kato K, Tsushima T, Chin K, Tomori A, Okuno T, Taniki T, Ura T, Matsushita H, Kojima T, Doki Y, Kusaba H, Fujitani K, Taira K, Seki S, Nakamura T, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Hironaka S, et al. Among authors: tsushima t. Cancer Sci. 2014 Sep;105(9):1189-95. doi: 10.1111/cas.12486. Cancer Sci. 2014. PMID: 25041052 Free PMC article. Clinical Trial.
Distribution of lymph node metastasis and clinical validity of gastric tube reconstruction in lower thoracic esophageal squamous cell carcinoma with gastric invasion.
Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yasui H, Takeuchi H, Kitagawa Y. Matsuda S, et al. Among authors: tsushima t. Ann Surg Oncol. 2015 Feb;22(2):617-23. doi: 10.1245/s10434-014-4017-7. Epub 2014 Aug 28. Ann Surg Oncol. 2015. PMID: 25164036
Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yokota T, Ogawa H, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y. Matsuda S, et al. Among authors: tsushima t. Ann Surg Oncol. 2015;22(6):1866-73. doi: 10.1245/s10434-014-4337-7. Epub 2015 Jan 7. Ann Surg Oncol. 2015. PMID: 25564176
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).
Kataoka K, Tsushima T, Mizusawa J, Hironaka S, Tsubosa Y, Kii T, Shibuya Y, Chin K, Katayama H, Kato K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Kataoka K, et al. Among authors: tsushima t. Jpn J Clin Oncol. 2015 May;45(5):494-8. doi: 10.1093/jjco/hyv012. Epub 2015 Feb 2. Jpn J Clin Oncol. 2015. PMID: 25646357 Clinical Trial.
576 results